Nuvasive Inc's ability to collect accounts receivable sequentially worsen to 4.89, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Nuvasive Inc's Accounts Receivable average collection period in the Jun 30 2023 quarter, has increased to 75 days, from 73 days, in the Mar 31 2023 quarter.

If we take a look into Healthcare sector 454 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2023 from 1202 to 2984.

What is Receivable Turnover Ratio?
What is Nuvasive Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NUVA Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	14.36 %	8.04 %	16.31 %	18.17 %	7.68 %
Y / Y Revenue Change	2.36 %	5.83 %	1.12 %	9.03 %	5.3 %
Receivable Turnover Ratio (TTM)	4.89	5.03	5.06	5.24	5.34
NUVA's Total Ranking	# 2984	# 1202	# 1936	# 1935	# 2621
Accounts Receivable average collection period days	75	73	72	70	68
Seq. Receivable Change	6.83 %	0.26 %	5.85 %	0.86 %	0.93 %
Seq. Revenue Change	3.27 %	0.74 %	3.44 %	-4.89 %	6.77 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 164
Healthcare Sector	# 455
Overall Market	# 2984

Receivable Turnover Ratio Statistics
High	Average	Low
7.33	6.12	4.89
(Dec 31 2012)		(Jun 30 2023)

NUVA Company Profile • Back to NUVA Efficiency Comparisons • Compare NUVA Receivables Turnover Ratio to its Competitors

Financial Statements
Nuvasive Inc's Accounts Receivable	$ 267 Millions	Visit NUVA's Balance sheet
Nuvasive Inc's Sales TTM	$ 1,226 Millions	Visit NUVA's Income Statement
Sources of NUVA's Revenues		Visit NUVA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NUVA's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NUVA's Growth Rates	NUVA's Roa	NUVA's Inventory Turnover Ratio	NUVA's Dividend Comparisons
NUVA's Profitability Ratios	NUVA's Roi	NUVA's Asset Turnover Ratio	NUVA's Dividend Growth
NUVA's Valuation Ratios	NUVA's Roe	NUVA's Financial Strength Ratios	NUVA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
Icu Medical Inc	12.46	$ 2,292.847 Millions	$ 184.062 Millions
Strata Critical Medical Inc	12.44	$ 190.117 Millions	$ 15.284 Millions
Vbi Vaccines Inc	12.39	$ 1.815 Millions	$ 0.147 Millions
Eton Pharmaceuticals Inc	12.33	$ 28.703 Millions	$ 2.327 Millions
Scienture Holdings Inc	12.14	$ 9.443 Millions	$ 0.778 Millions
Sunlink Health Systems Inc	12.01	$ 48.489 Millions	$ 4.037 Millions
Teladoc Health Inc	12.00	$ 2,530.761 Millions	$ 210.854 Millions
Intellia Therapeutics Inc	11.95	$ 53.039 Millions	$ 4.438 Millions
Gelesis Holdings Inc	11.91	$ 12.140 Millions	$ 1.020 Millions
Avita Medical Inc	11.81	$ 40.850 Millions	$ 3.458 Millions
Emmaus Life Sciences Inc	11.77	$ 28.381 Millions	$ 2.411 Millions
Surmodics Inc	11.77	$ 130.602 Millions	$ 11.098 Millions
Precipio inc	11.74	$ 10.956 Millions	$ 0.933 Millions
Amylyx Pharmaceuticals Inc	11.55	$ 191.874 Millions	$ 16.618 Millions
Merus N v	11.54	$ 41.222 Millions	$ 3.571 Millions
Integrated Biopharma Inc	11.50	$ 50.061 Millions	$ 4.353 Millions
Zymeworks Inc	11.49	$ 447.704 Millions	$ 38.966 Millions
Milestone Scientific Inc	11.41	$ 9.944 Millions	$ 0.872 Millions
Semler Scientific inc	11.28	$ 64.653 Millions	$ 5.733 Millions
Intercept Pharmaceuticals inc	10.99	$ 306.483 Millions	$ 27.892 Millions
Utah Medical Products Inc	10.91	$ 51.789 Millions	$ 4.749 Millions
Neuraxis Inc	10.90	$ 0.646 Millions	$ 0.059 Millions
Mymetics Corporation	10.87	$ 0.755 Millions	$ 0.069 Millions
National Healthcare Corp	10.78	$ 1,087.541 Millions	$ 100.846 Millions
Option Care Health Inc	10.78	$ 4,133.051 Millions	$ 383.360 Millions
Neurometrix Inc	10.77	$ 7.196 Millions	$ 0.668 Millions
Nrc Health	10.61	$ 148.469 Millions	$ 13.988 Millions
Arcturus Therapeutics Holdings Inc	10.57	$ 264.466 Millions	$ 25.023 Millions
Atrion Corporation	10.46	$ 171.317 Millions	$ 16.378 Millions
Sunshine Biopharma Inc	10.17	$ 14.528 Millions	$ 1.428 Millions

Date modified: 2026-09-12T06:12:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.